TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31003690

Group type: EXPERIMENTAL
Intervention: Topical sesame oil with massage (10 drops, twice a day for 7 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Massage only (control group)
Number of subjects: 60
Study: 26544173

Group type: EXPERIMENTAL
Intervention: Nurse-led structured discharge planning program
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard routine care
Number of subjects: 143
Study: 24988438

Group type: EXPERIMENTAL
Intervention: RAL 800 mg by chewing
Number of subjects: 12

Group type: COMPARATOR
Intervention: RAL 400 mg by swallowing
Number of subjects: 12
Study: 23700028

Group type: EXPERIMENTAL
Intervention: Consent documents with high processability, eighth-grade reading level, and graphics
Number of subjects: 640

Group type: COMPARATOR
Intervention: Consent documents without high processability, eighth-grade reading level, and graphics
Number of subjects: 640
Study: 20817535

Group type: EXPERIMENTAL
Intervention: Laserlight visual cue
Number of subjects: 26
Study: 19865065

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 terclatrate (QTer) 200 mg orally once daily for 7 days before noise exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 terclatrate (QTer)
Number of subjects: 20
Study: 17846807

Group type: EXPERIMENTAL
Intervention: Finger cover made of soft, thin polyester non‐woven fabric
Number of subjects: 12

Group type: COMPARATOR
Intervention: No finger cover (control)
Number of subjects: 12
Study: 15613828

Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Hand holding
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 11691521

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 1829

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 1829

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1829
Study: 9158165

Group type: EXPERIMENTAL
Intervention: Clonidine (transdermal, given for 5 days)
Number of subjects: 14
Study: 8086609

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 3436102

Group type: EXPERIMENTAL
Intervention: 80 mmol/day KCl (Slow‐K, Ciba Geigy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 44
Study: 27010325

Group type: EXPERIMENTAL
Intervention: Observational method
Number of subjects: 451

Group type: COMPARATOR
Intervention: Incident reports
Number of subjects: 451

Group type: COMPARATOR
Intervention: Global Trigger Tool method
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Observational data
Number of subjects: 451
Study: 31161227

Group type: EXPERIMENTAL
Intervention: Orthodontic space closure initiated after 2-4 weeks (group A, n=41)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Orthodontic space closure initiated ≥ 12 weeks after tooth extraction (group B, n=25)
Number of subjects: 25
Study: 28341782

Group type: EXPERIMENTAL
Intervention: GDF-15
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: NTproBNP
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: hs-TnT
Number of subjects: 861

Group type: COMPARATOR
Intervention: NTproBNP and hs-TnT
Number of subjects: 861
Study: 25906565

Group type: EXPERIMENTAL
Intervention: Triple-strong stimulation therapy group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Acupoint plaster therapy group
Number of subjects: 120
Study: 24374951

Group type: EXPERIMENTAL
Intervention: PCR technique (broad-range 16S rDNA detection, runtime 6 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Blood culture (monitored for 6 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PCR technique
Number of subjects: 50
Study: 22012043

Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 32
Study: 19784467

Group type: EXPERIMENTAL
Intervention: InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm(2) dose, 10‐s irradiation time, followed by conventional treatment (Mucositis Formula)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional treatment (Mucositis Formula) only
Number of subjects: 22
Study: 16825002

Group type: EXPERIMENTAL
Intervention: Calcification group (moderate or heavily calcified aortic valve)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Noncalcification group (no or mildly calcified aortic valve)
Number of subjects: 55
Study: 15116086

Group type: EXPERIMENTAL
Intervention: Modified dairy butter fat (reduced saturated:unsaturated fatty acid ratio)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional high saturated butter fat
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both dietary treatments
Number of subjects: 18
Study: 14649615

Group type: COMPARATOR
Intervention: 4-minute, 1.23% APF gel treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AL irradiation of 11.5 J/cm2 (0.23 1‐W, 5‐mm beam size, 10 seconds)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AL irradiation followed by APF gel treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 12
Study: 10993625

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (LC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (LC)
Number of subjects: 43
Study: 8843757

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 15
Study: 1512910

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) plus standardized rehabilitation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standardized rehabilitation alone
Number of subjects: 102
Study: 6700643

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg every 6 hours for 48 hours)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31376858

Group type: EXPERIMENTAL
Intervention: Saturated fat tax (mean absolute difference 1.77%)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Sugar tax (mean absolute difference 1.09%)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Salt tax (mean absolute difference 1.31%)
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Control (no change in prices)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Sweetened beverage tax (0.18% increase)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Fruit and vegetable subsidy (0.41% increase)
Number of subjects: 1132
Study: 30327362

Group type: EXPERIMENTAL
Intervention: Insulin Pump
Number of subjects: 248

Group type: COMPARATOR
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 248
Study: 26205890

Group type: EXPERIMENTAL
Intervention: Exercise + placebo (D‐Ex+)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Exercise + vitamin D 800 IU/day (D+Ex+)
Number of subjects: 409

Group type: COMPARATOR
Intervention: No exercise + placebo (D‐Ex‐)
Number of subjects: 409

Group type: COMPARATOR
Intervention: No exercise + vitamin D 800 IU/day (D+Ex‐)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: D‐Ex+
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: D+Ex+
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: D‐Ex‐
Number of subjects: 409
Study: 25188224

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Untreated eyes (control group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Low-risk untreated eyes
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-risk treated eyes (LPI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: High-risk untreated eyes
Number of subjects: 72

Group type: COMPARATOR
Intervention: Low-risk eyes
Number of subjects: 72
Study: 22000577

Group type: COMPARATOR
Intervention: Core decompression
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cell instillation after core decompression
Number of subjects: 40
Study: 20335871

Group type: EXPERIMENTAL
Intervention: Afroze incision
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Millard incision
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Pfeifer incision
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: All three incisions
Number of subjects: 1200
Study: 17875558

Group type: EXPERIMENTAL
Intervention: Whole body vibration (20 Hz, 5 mm amplitude, 1 minute, 6 times in one session)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no vibration, same standing protocol)
Number of subjects: 16
Study: 16178493

Group type: EXPERIMENTAL
Intervention: Magnetic insoles
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham-magnetic insoles
Number of subjects: 83
Study: 12047427

Group type: EXPERIMENTAL
Intervention: Body mass index greater than 30
Number of subjects: 15454

Group type: COMPARATOR
Intervention: Body mass index of 20-24.99
Number of subjects: 15454

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 15454
Study: 10572341

Group type: EXPERIMENTAL
Intervention: Milnacipran (SNRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCA
Number of subjects: 0

Group type: COMPARATOR
Intervention: SSRI
Number of subjects: 0
Study: 7787850

Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation with 40% body weight supported
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation with full body weight and 20% body weight supported
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Harness-supported treadmill ambulation at 1.34 m/sec (3.0 mph)
Number of subjects: 2
Study: 2336873

Group type: EXPERIMENTAL
Intervention: Immunotherapy with a vaccine consisting of autoclaved Mycobacterium w
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chemotherapy and placebo injections
Number of subjects: 54
Study: 377219

Group type: EXPERIMENTAL
Intervention: Weekly immunotherapy combining BCG and irradiated leukaemic cells
Number of subjects: 31

Group type: COMPARATOR
Intervention: Monthly reinduction chemotherapy
Number of subjects: 31
Study: 30160559

Group type: EXPERIMENTAL
Intervention: Morning exercise (09:00 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Afternoon exercise (16:00 h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No exercise (CON)
Number of subjects: 12
Study: 28086871

Group type: EXPERIMENTAL
Intervention: iCaPPS- Rehab© for rehabilitation of stroke patients at community level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iCaPPS- Swallow© for screening and managing stroke related swallowing problems
Number of subjects: 0
Study: 25744500

Group type: EXPERIMENTAL
Intervention: Accelerated high-frequency (HF) rTMS treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 15
Study: 25158369

Group type: EXPERIMENTAL
Intervention: Dynamic visual presentation method (soundless animated video presentation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Static visual presentation method (wordless picture book)
Number of subjects: 20
Study: 20536910

Group type: EXPERIMENTAL
Intervention: Maximal oxygen consumption (VO(2max)) measured during a maximal exercise stress test on a bicycle ergometer with a linear workload increase of 20 W/min.
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Maximal metabolic equivalents (METs) and maximal workload measured during the same exercise test.
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Chronic diseases (0, 1, 2 or ≥3) as a variable affecting VO(2max).
Number of subjects: 1349
Study: 19447570

Group type: COMPARATOR
Intervention: Sustained-release (SR) bupropion plus transdermal nicotine patch
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 16512758

Group type: EXPERIMENTAL
Intervention: SRP plus chlorhexidine chip
Number of subjects: 34

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 34
Study: 12725547

Group type: EXPERIMENTAL
Intervention: Skin-to-skin group
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Mother's arms group
Number of subjects: 176

Group type: COMPARATOR
Intervention: Nursery group
Number of subjects: 176
Study: 11545470

Group type: EXPERIMENTAL
Intervention: Pantomiming tool‐use gestures with either the left hand or right hand
Number of subjects: 10

Group type: COMPARATOR
Intervention: Repetitive, oppositional movements between thumb and index finger (Control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Right-hand praxis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Left-hand praxis
Number of subjects: 10
Study: 9270638

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (cisplatin and 5-fluorouracil)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Surgical therapy alone
Number of subjects: 147
Study: 7876487

Group type: EXPERIMENTAL
Intervention: Double incision open technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard incision technique
Number of subjects: 30
Study: 3060625

Group type: EXPERIMENTAL
Intervention: Cefmetazole (CMZ)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Cephalothin (C)
Number of subjects: 403
Study: 1346414

Group type: EXPERIMENTAL
Intervention: Dermatan sulphate
Number of subjects: 0
Study: 332472

Group type: EXPERIMENTAL
Intervention: Imipramine pamoate
Number of subjects: 57

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 57
Study: 30475752

Group type: EXPERIMENTAL
Intervention: 6-month trunk prevention training program
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (not performing trunk prevention training)
Number of subjects: 103
Study: 27852098

Group type: EXPERIMENTAL
Intervention: Water plus 100 mg simethicone (group B)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Water plus 100 mg simethicone plus 600 mg N-acetylcysteine (group C)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Water (placebo, group A)
Number of subjects: 297
Study: 25912524

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (n=38)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Incubator group (n=37)
Number of subjects: 80
Study: 24018711

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg o.d.) and ketoconazole (200 mg t.d.s.)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tamsulosin (0.4 mg o.d.) and placebo
Number of subjects: 106
Study: 21233029

Group type: EXPERIMENTAL
Intervention: Budesonide 64 μg/dose nasal spray
Number of subjects: 48

Group type: COMPARATOR
Intervention: Budecort Aqua® 64 μg/dose nasal spray
Number of subjects: 48
Study: 18653484

Group type: EXPERIMENTAL
Intervention: Licofelone (200 mg twice a day)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Naproxen (500 mg twice a day)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Both Licofelone and Naproxen
Number of subjects: 355
Study: 17561796

Group type: EXPERIMENTAL
Intervention: Electronic Group (integrated glucose meters and electronic logbooks)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Paper Group (conventional meters and paper logbooks)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Integrated meters/logbooks (continued use)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conventional meters/logbooks (continued use or switching)
Number of subjects: 205
Study: 14700144

Group type: EXPERIMENTAL
Intervention: 10 per cent sulfur ointment
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.3 per cent gamma benzene hexachloride gel
Number of subjects: 100
Study: 10975210

Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Animal insulin
Number of subjects: 52
Study: 8865523

Group type: EXPERIMENTAL
Intervention: Factor VII:C levels
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Genotype, body mass index, cholesterol, triglycerides, gender
Number of subjects: 270

Group type: COMPARATOR
Intervention: Severity of atheroma
Number of subjects: 270

Group type: COMPARATOR
Intervention: History of myocardial infarction
Number of subjects: 270

Group type: COMPARATOR
Intervention: Genotype-environment interaction
Number of subjects: 270
Study: 1632401

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor
Number of subjects: 6273

Group type: COMPARATOR
Intervention: Registry data collection
Number of subjects: 6273
Study: 6431586

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 31

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 31
Study: 31246588

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham PCI
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 200
Study: 28538079

Group type: EXPERIMENTAL
Intervention: Music listening during LEEP
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no music) during LEEP
Number of subjects: 150
Study: 25359382

Group type: EXPERIMENTAL
Intervention: COBRA Classic (methotrexate (MTX)+ sulfasalazine+60 mg prednisone tapered to 7.5 mg daily from W7)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: COBRA Slim (MTX+30 mg prednisone tapered to 5 mg from W6)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: COBRA Avant-Garde (MTX+leflunomide+30 mg prednisone tapered to 5 mg from W6)
Number of subjects: 400
Study: 23526739

Group type: EXPERIMENTAL
Intervention: ARMS P3F+
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: ARMS P7F+
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: ERMS
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: ARMSn (without detectable fusion)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: ARMSn
Number of subjects: 434
Study: 21810636

Group type: EXPERIMENTAL
Intervention: Air cleaners only
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Air cleaners plus health coach
Number of subjects: 126

Group type: COMPARATOR
Intervention: Delayed air cleaner (control)
Number of subjects: 126
Study: 19152024

Group type: EXPERIMENTAL
Intervention: Educational video intervention (18-min duration)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Educational video intervention
Number of subjects: 196
Study: 17092365

Group type: EXPERIMENTAL
Intervention: Wheat-fibre
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oat-fibre
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (white bread)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All test meals
Number of subjects: 14
Study: 14979845

Group type: EXPERIMENTAL
Intervention: Paquin School Program
Number of subjects: 877

Group type: COMPARATOR
Intervention: Comparison schools
Number of subjects: 877
Study: 10912846

Group type: EXPERIMENTAL
Intervention: PTH (1-34) 400 IU/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 9310875

Group type: EXPERIMENTAL
Intervention: EMDOGAIN
Number of subjects: 107

Group type: COMPARATOR
Intervention: Flap surgery without EMDOGAIN
Number of subjects: 107
Study: 8104978

Group type: EXPERIMENTAL
Intervention: Twice-daily skin preparation with 10% aqueous povidone-iodine for 48 h preoperatively (Group A, N = 34)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No skin preparation (Group B, N = 30)
Number of subjects: 64
Study: 3516177

Group type: EXPERIMENTAL
Intervention: Ampicillin sodium/amoxicillin trihydrate therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31054010

Group type: EXPERIMENTAL
Intervention: Probiotic (Symprove™, 1 ml/kg/day for 4 weeks)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Probiotic (Symprove™)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 28129288

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 100
Study: 25923274

Group type: EXPERIMENTAL
Intervention: Chronic otitis media and cholesteatoma patients (n=51)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Chronic otitis media without cholesteatoma patients (control group, n=30)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Study group (n=51)
Number of subjects: 51
Study: 23506314

Group type: EXPERIMENTAL
Intervention: Grape seed oil (GSO)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sunflower oil (SFO)
Number of subjects: 44
Study: 21372193

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sulfasalazine
Number of subjects: 76
Study: 18207598

Group type: EXPERIMENTAL
Intervention: Low-dose daily cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperfractionated radiotherapy (77Gy in 70 fractions in 35 treatment days)
Number of subjects: 0
Study: 16810109

Group type: EXPERIMENTAL
Intervention: stavudine/didanosine
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: zidovudine/lamivudine with nelfinavir, efavirenz, or both
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: ART initiation
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Virologic suppression (VS)
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Persistent T-cell activation
Number of subjects: 980
Study: 12716243

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 212
Study: 11072770

Group type: EXPERIMENTAL
Intervention: Swim/Bike trial (SB) - 3000 m swimming followed by 3-h cycling
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial (CON) - 3-h cycling without prior swimming
Number of subjects: 8
Study: 9171065

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (80 mg in 8 ml of isotonic saline)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Isotonic saline (1 ml)
Number of subjects: 158
Study: 7584257

Group type: EXPERIMENTAL
Intervention: Unfamiliar target events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distinctive target events relative to local context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indirect retrospective memory task (word fragment completion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicit retrospective memory tasks (recall and recognition)
Number of subjects: 0
Study: 2957500

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine bilateral infiltration beneath the site of ring application
Number of subjects: 200
Study: 31959707

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOA)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKA)
Number of subjects: 221